[1]Raquel R, Bruno S, Ignacio H, et al.The role of thrombopoietin inthe thrombocytopenia of patients with liver cirrhosis[J].Am J Gas-troenterol, 2005, 100 (6) ∶1311-1316.
|
[2]党双锁.肝硬化失代偿期外周血细胞减少成因机制[J].世界华人消化杂志, 2007, 15 (27) ∶2861-2864.
|
[3]中华医学会.病毒性肝炎防治方案[J].中华预防医学杂志, 2000, 1 (1) ∶44-52.
|
[4]隋杰, 肖灿鹏.人血小板生成素的研究进展[J].生物技术通讯, 2002, 13 (1) ∶76-82.
|
[5]Shimabukuro R, Kawanaka H, Tomikawa M, et al.Effect of throm-bopoietin on platelet counts and liver regeneration after partial hepa-tectomy in a rat model[J].Surg Today, 2009, 39 (2) ∶1054-1059.
|
[6]de Sauvage FJ, Carver-Moore K, Luoh SM, et al.Physiologicalregulation of early and late stages of megakaryocytopoiesis by throm-bopoietin[J].J Exp Med, 1996, 183 (2) ∶651-656.
|
[7]Martin TG 3rd, Somberg KA, Meng YG, et al.Thrombopoietin lev-els in patients with cirrhosis before and after orthotopic liver trans-plantation[J].Ann Intern Med, 1997, 127 (4) ∶285-288.
|
[8]Weksler BB.The pathophysiology of thrombocytopenia in hepatitisC virus infection and chronic liver disease[J].Aliment PharmacolTher, 2007, 26 (1) ∶13-19.
|
[9]Metcalf D.Hematopoietic cytokines[J].Blood, 2008, 111 (2) ∶485-491.
|
[10]Berghams T, Paesmans M, Lafitte JJ, et al.Therapeutic use ofgranulocyte and granulocyte-macrophage colony-stimulating fac-tors in febrile neutropenic cancer patients-A systematic review ofthe literature with meta-analysis[J].Support Care Cancer, 2002, 10 (3) ∶181-188.
|
[11]Kubotaa, Okamura S, Omori F, et al.High serum levers of granulo-cyte-macrophage colony-stimulating factor in patients with liver-cirrhosis and granulocytopenia[J].Clin Lab Haematol, 1995, 17 (1) ∶61-63.
|
1. | 杨豪俊,焦宇文,刘寒旸,林煌,钱峻. 腹腔镜袖状胃切除结合十二指肠空肠吻合术治疗肥胖并非酒精性脂肪性肝病的可行性及安全性分析. 中华普外科手术学杂志(电子版). 2020(05): 472-475 . ![]() |